Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Jan 28, 2017 | $35.2B |
| FY2017, ended Feb 3, 2018 | $39.3B |
| FY2018, ended Feb 2, 2019 | $36.7B |
| FY2019, ended Feb 1, 2020 | $55.5B |
| FY2020, ended Jan 30, 2021 | $90.3B |
| FY2021, ended Jan 29, 2022 | $101B |
| FY2022, ended Jan 28, 2023 | $77.6B |
| FY2023, ended Feb 3, 2024 | $67.2B |
| FY2024, ended Feb 1, 2025 | $62.8B |
| FY2025, ended Jan 31, 2026 | $47.8B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $65.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Jan 28, 2017 | $70.3B |
| FY2017, ended Feb 3, 2018 | $72.7B |
| FY2018, ended Feb 2, 2019 | $75.4B |
| FY2019, ended Feb 1, 2020 | $78.1B |
| FY2020, ended Jan 30, 2021 | $93.6B |
| FY2021, ended Jan 29, 2022 | $106B |
| FY2022, ended Jan 28, 2023 | $109B |
| FY2023, ended Feb 3, 2024 | $107B |
| FY2024, ended Feb 1, 2025 | $107B |
| FY2025, ended Jan 31, 2026 | $105B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $108B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Jan 28, 2017 | $2.73B | $3.90B |
| FY2017, ended Feb 3, 2018 | $2.91B | $4.40B |
| FY2018, ended Feb 2, 2019 | $2.94B | $2.46B |
| FY2019, ended Feb 1, 2020 | $3.28B | $4.09B |
| FY2020, ended Jan 30, 2021 | $4.37B | $7.88B |
| FY2021, ended Jan 29, 2022 | $6.95B | $5.08B |
| FY2022, ended Jan 28, 2023 | $2.78B | −$1.51B |
| FY2023, ended Feb 3, 2024 | $4.14B | $3.81B |
| FY2024, ended Feb 1, 2025 | $4.09B | $4.48B |
| FY2025, ended Jan 31, 2026 | $3.71B | $2.83B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $4.39B | $4.46B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Jan 28, 2017 | $2.51B |
| FY2017, ended Feb 3, 2018 | $2.64B |
| FY2018, ended Feb 2, 2019 | $1.56B |
| FY2019, ended Feb 1, 2020 | $2.58B |
| FY2020, ended Jan 30, 2021 | $8.51B |
| FY2021, ended Jan 29, 2022 | $5.91B |
| FY2022, ended Jan 28, 2023 | $2.23B |
| FY2023, ended Feb 3, 2024 | $3.81B |
| FY2024, ended Feb 1, 2025 | $4.76B |
| FY2025, ended Jan 31, 2026 | $5.49B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $5.41B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Jan 28, 2017 | $11.7B |
| FY2017, ended Feb 3, 2018 | $10.4B |
| FY2018, ended Feb 2, 2019 | $10.2B |
| FY2019, ended Feb 1, 2020 | $9.99B |
| FY2020, ended Jan 30, 2021 | $10.6B |
| FY2021, ended Jan 29, 2022 | $11.6B |
| FY2022, ended Jan 28, 2023 | $14.1B |
| FY2023, ended Feb 3, 2024 | $14.2B |
| FY2024, ended Feb 1, 2025 | $13.9B |
| FY2025, ended Jan 31, 2026 | $14.4B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $15.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 17.8% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Jan 28, 2017 | 553M |
| FY2017, ended Feb 3, 2018 | 539M |
| FY2018, ended Feb 2, 2019 | 516M |
| FY2019, ended Feb 1, 2020 | 501M |
| FY2020, ended Jan 30, 2021 | 499M |
| FY2021, ended Jan 29, 2022 | 462M |
| FY2022, ended Jan 28, 2023 | 460M |
| FY2023, ended Feb 3, 2024 | 462M |
| FY2024, ended Feb 1, 2025 | 456M |
| FY2025, ended Jan 31, 2026 | 453M |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | 454M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Jan 28, 2017 | $3.71B | $113M |
| FY2017, ended Feb 3, 2018 | $1.05B | $112M |
| FY2018, ended Feb 2, 2019 | $2.12B | $132M |
| FY2019, ended Feb 1, 2020 | $1.56B | $147M |
| FY2020, ended Jan 30, 2021 | $745M | $200M |
| FY2021, ended Jan 29, 2022 | $7.19B | $228M |
| FY2022, ended Jan 28, 2023 | $2.65B | $220M |
| FY2023, ended Feb 3, 2024 | $0 | $251M |
| FY2024, ended Feb 1, 2025 | $1.01B | $304M |
| FY2025, ended Jan 31, 2026 | $408M | $281M |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $153M | $302M |
Valuation
At current price- Market Cap
- $67.2B
- P/E
- 15.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.6×
- Price / Book
- 3.8×
- EV / EBITDA
- 8.4×
Growth
Trailing 12 months- Revenue (TTM)
- $108B
- Revenue Growth YoY
- 2.0%
- Revenue CAGR 3Y
- −1.3%
- Revenue CAGR 5Y
- 2.3%
- EPS Growth YoY
- 12.4%
- Net Income Growth YoY
- 11.8%
Profitability
Trailing 12 months- Gross Margin
- 29.3%
- Operating Margin
- 5.6%
- Net Margin
- 4.1%
- FCF Margin
- 4.1%
- Return on Equity
- 26.4%
Earnings
Trailing 12 months- Net Income
- $4.39B
- EPS (diluted)
- $9.64
- EBITDA
- $9.20B
- Operating Income
- $6.02B
Balance Sheet
As of Aug 1, 2026- Cash and cash equivalents
- $5.41B
- Total Debt
- $15.4B
- Net Debt
- $9.95B
- Total Assets
- $61.2B
- Total Liabilities
- $43.4B
- Shareholders' Equity
- $17.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $8.72B
- Capital Expenditure
- $4.27B
- Free Cash Flow
- $4.46B
Dividends and risk
Last 12 months- Dividend Yield
- 3.1%
- Dividend / Share
- $4.58
- Beta (5Y)
- 0.99
Every ratio is calculated from the company’s reported figures.